ERBB2 and neoplasm: Given the well-established role of NK cells in the anti-tumor activity of trastuzumab (62, 85), also observed in the direct co-culture assays (Supplementary Figure 3A), we assessed the modulation of the NK cell phenotype induced by anti-HER2 antibody challenge in the models.